Open Access. Powered by Scholars. Published by Universities.®

Law Commons™

Open Access. Powered by Scholars. Published by Universities.®

Food and Drug Law

University of Nevada, Las Vegas

Book Gallery

Articles 1 - 1 of 1

Full-Text Articles in Law

Retroviral Protease (Rvp) Ddi2 Is A Viable Alternative For Full-Length (Fl) Ddi2, Ethan Chi Dec 2022

Retroviral Protease (Rvp) Ddi2 Is A Viable Alternative For Full-Length (Fl) Ddi2, Ethan Chi

Undergraduate Research Symposium Lightning Talks

Proteasome inhibitors are drugs used to treat multiple myeloma. Currently, three are approved by the FDA.

Go to article